Skip to main content
. 2018 Jan 8;50(4):1304–1315. doi: 10.4143/crt.2017.463

Fig. 3.

Fig. 3.

Comparison of the overall survival (A), progression-free survival (B), locoregional failure (C), and distant metastasise-free survival (D) in the matched cohort between patients with (n=43) and without (n=43) induction chemotherapy (IC). CCRT, concurrent chemoradiotherapy.